Bedaquiline: how better to use it

Jose A Caminero^{1

2}, Alberto Piubello^{2

3}, Anna Scardigli⁴, Giovanni Battista Migliori⁵

Affiliations

¹ Pneumology Dept, Hospital General de Gran Canaria "Dr. Negrin", Las Palmas de GC, Spain.
² Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
³ MDR-TB Division, Damien Foundation, Brussels, Belgium.
⁴ The Global Fund to Fight Aids, Tuberculosis and Malaria, Geneva, Switzerland.
⁵ Maugeri Care and Research Institute, IRCCS, Tradate, Italy giovannibattista.migliori@icsmaugeri.it.

Free article

Comment

Jose A Caminero et al. Eur Respir J. 2017.

Free article

. 2017 Nov 9;50(5):1701670.

doi: 10.1183/13993003.01670-2017. Print 2017 Nov.

Jose A Caminero^{1

2}, Alberto Piubello^{2

3}, Anna Scardigli⁴, Giovanni Battista Migliori⁵

¹ Pneumology Dept, Hospital General de Gran Canaria "Dr. Negrin", Las Palmas de GC, Spain.
² Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
³ MDR-TB Division, Damien Foundation, Brussels, Belgium.
⁴ The Global Fund to Fight Aids, Tuberculosis and Malaria, Geneva, Switzerland.
⁵ Maugeri Care and Research Institute, IRCCS, Tradate, Italy giovannibattista.migliori@icsmaugeri.it.

No abstract available

Comment on

Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.
Caminero JA, Piubello A, Scardigli A, Migliori GB. Caminero JA, et al. Eur Respir J. 2017 Jul 5;50(1):1700648. doi: 10.1183/13993003.00648-2017. Print 2017 Jul. Eur Respir J. 2017. PMID: 28679614 No abstract available.
Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosis.
Furin J, Lessem E, Cox V. Furin J, et al. Eur Respir J. 2017 Nov 9;50(5):1701552. doi: 10.1183/13993003.01552-2017. Print 2017 Nov. Eur Respir J. 2017. PMID: 29122918 No abstract available.